• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    More On ATE.V

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Antibe Therapeutics Inc. (ATE.V)

    -TSXV
    0.44 0.00(0.00%) Dec 18
    Add to Portfolio
    Prev Close:0.44
    Open:0.42
    Bid:0.45
    Ask:0.53
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.42 - 0.44
    52wk Range:0.39 - 0.88
    Volume:5,200
    Avg Vol (3m):26,722
    Market Cap:16.28M
    P/E (ttm):N/A
    EPS (ttm):-0.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for ATE.V

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :-0.10
    Quarterly EPS Est (Dec-14) :-0.04
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antibe Therapeutics Inc. originates, develops, and out-licenses patent-protected pharmaceuticals for pharmaceutical and biotechnology companies. The company’s lead product includes ATB-346, a hydrogen sulfide-releasing derivative of naproxen ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback